The impact of caffeine on vasodilator stress perfusion studies.
Lapeyre
Andre C
AC
Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. alapeyre@mayo.edu
Goraya
Tauqir Y
TY
Johnston
Donald L
DL
Gibbons
Raymond J
RJ
D016477:Artifacts; D002110:Caffeine / Q000494:pharmacology*; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging*; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000187:drug effects; D004347:Drug Interactions; D005080:Exercise Test / Q000187:drug effects* / Q000379:methods*; D006321:Heart / Q000000981:diagnostic imaging* / Q000187:drug effects*; D006801:Humans; D011877:Radionuclide Imaging; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors
D014665:Vasodilator Agents; D002110:Caffeine